The oral analgesics segment held about half of the market share in 2015, and is anticipated to maintain this trend throughout the forecast period. This is mainly attributed to the higher use of oral analgesics as compared to intravenous and topical analgesics. Economical cost, ease of availability, and high popularity of oral analgesics are the key factors responsible for the dominance of this segment.
Analgesics market would reach $26.4 billion by 2022. The non-opioids segment would continue to be the highest revenue-generating segment throughout the forecast period. North America and Europe, are likely to continue their lead through 2022; they collectively accounted for over half of the overall market share in the global analgesics market in 2015.
Frequent pain and aches experienced by the ageing population, increasing incidences of cardiovascular disease (CVD), cancer, & arthritis, and rising investments in R&D by the public & private sectors, with key focus on the classes of compounds to formulate new therapeutics, are the major factors boosting the market growth. However, factors such as uncontrolled prescriptions of opioids and drug abuse, leading to approximately 28,000 deaths in the U.S. every year, and insufficient regulatory guidelines, especially against opioid analgesics, are likely to impede the market growth. Furthermore, the increase in popularity of personalized medicine is expected to provide numerous growth opportunities for the analgesics market in the near future.
The oral analgesics segment held about half of the market share in 2015, and is anticipated to maintain this trend throughout the forecast period. This is mainly attributed to the higher use of oral analgesics as compared to intravenous and topical analgesics. Economical cost, ease of availability, and high popularity of oral analgesics are the key factors responsible for the dominance of this segment.
Key findings of the study:
Opioid analgesics is expected to grow at a CAGR of 7.1% during the forecast period.
In the route of the administration market analysis, the transdermal analgesics segment is projected to grow fastest during the forecast period, whereas the oral analgesics segment is expected to grow at a CAGR of 1.5%.
North America accounted for about one-third of the global analgesics market in 2015.
The U.S. occupies the major market share within North America market followed by Canada, together accounting for a market share close to 90.0% of the North American analgesics market.
The Asia-Pacific region is anticipated to be the fastest growing analgesics market, followed by LAMEA region.
Japan and China are the major market shareholders in Asia-Pacific with a combined market share of approximately 50% of the analgesics market in this region.
North America accounted for a major share of the overall analgesics market revenue in 2015, owing to large number of pharmaceutical companies in this region. The analgesics market in developing economies, such as China and India, has numerous growth opportunities because of the availability of cheap raw materials and economical workforce. The global analgesics manufacturers are relocating their facilities into developing economies by agreements or acquisitions with local players. Moreover, increasing use of analgesics in countries such Nigeria, China, and India supports the growth of analgesics in developing economies.
The key companies profiled in the report are Bayer AG, Novartis AG, GlaxoSmithKline PLC, Pfizer Inc., Johnson & Johnson, Reckitt Benckiser (RB), Endo Pharmaceuticals, Bristol-Myers Squibb, Eli Lilly and Company, and Sanofi S.A.
Surgical microscopes market would reach $818 million by 2022 from $447 million in 2015, growing a CAGR of 8.9% from 2016 to 2022. Ophthalmology application segment is expected to remain the highest revenue-generating segment throughout the forecast period. North America held the leading position in the global market in 2015, and is expected to maintain its lead throughout the study period. The demand for surgical microscopes has witnessed tremendous growth due to growth in global geriatric population, increase in R&D activity in life science sector, growth in health care infrastructure, and increase in demand for minimally invasive surgeries. In addition, governmental funding & support for implementing the healthcare infrastructure and technological advancement are some of the factors anticipated to play a major role in the growth of the developed markets. However, sale of used and refurbished equipment and high pricing of equipment in develo...
The report provides a detailed analysis of changing market dynamics, top segments, value chain, key investment pockets, regional scenario, and competitive landscape. For Right Perspective and Competitive Insights, Get Sample Report at: https://www.alliedmarketresearch.com/request-sample/5093 Increase in obesity worldwide, rise in aesthetic consciousness, and advancements in the field of body contouring facilitate the growth in the market. However, high cost related to body contouring procedures restrains market growth. On the other hand, the increase in medical tourism and untapped potential in emerging economies create new opportunities. Comprehensive competitive analysis and profiles of major market players, such as Leading market players analyzed in the report include Allergan plc, Bausch Health Companies Inc., Hologic, Inc., Shanghai Fosun Pharmaceutical Group Co., Ltd., Erchonia Corporation, MicroAire Surgical Instruments, LLC, Cutera, Inc., InMode Aesthetic Solutions,...
Global Micromanipulators Market report by Allied Market Research, states that the sales of micromanipulators are projected to grow at a CAGR of 25.8% between 2015 and 2020. In 2014, cell micromanipulation application segment dominated the micromanipulators market in terms of both, revenue and volume, and is expected to retain its lead position during the forecast period. Download the Sample Report @ http://bit.ly/2wQXjI4 Shift from conventional manual micromanipulators to advanced electric or hydraulic versions, rising global infertility rates, and expanding base of semiconductors and microelectronics in the emerging economies are primarily leveraging the growth of the market. In addition, increasing usage of micromanipulator novel applications such as genomics, proteomics, transgenesis and cell cloning would provide continued growth thrust for the market. However, factors such as high cost associated with advanced micromanipulators, lack of awareness among potential e...
Comments
Post a Comment